Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs
Authors:
- Jeff C. H. KoJKJeff C. H. Ko
- Steven M. FoxSFSteven M. Fox
- Ronald E. MandsagerRMRonald E. Mandsager
- 1 January 2001
- journal article
- clinical trial
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 218 (1) , 52-58
Abstract
Objective—To determine the cardiorespiratory effects of preemptive atropine administration in dogs sedated with medetomidine. Design—Randomized crossover trial. Animals—12 healthy adult dogs. Procedures—Dogs underwent 6 treatments. Each treatment consisted of administration of atropine (0.04 mg/kg [0.018 mg/lb] of body weight, IM) or saline solution (0.9% NaCl, 1 ml, IM) and administration of medetomidine (10, 20, or 40 µg/kg [4.5, 9.1, or 18.2µg/lb], IM) 10 minutes later. Treatments were administered in random order, with a minimum of 1 week between treatments. Cardiorespiratory effects before and after atropine and medetomidine administration were assessed. Duration of lateral recumbency and quality of sedation and recovery were assessed. Results—Bradycardia (heart rate < 60 beats/min) was seen in all dogs when saline solution was administered followed by medetomidine, and the dose of medetomidine was not associated with severity or frequency of bradycardia or second-degree heart block. However, a medetomidine dose-dependent increase in mean and diastolic blood pressures was observed, regardless of whether dogs received saline solution or atropine. Preemptive atropine administration effectively prevented bradycardia and seconddegree heart block but induced pulsus alternans and hypertension. The protective effects of atropine against bradycardia lasted 50 minutes. Blood gas values were within reference limits during all treatments and were not significantly different from baseline values. Higher doses of medetomidine resulted in a longer duration of lateral recumbency. Conclusions and Clinical Relevance—Preemptive administration of atropine in dogs sedated with medetomidine effectively prevents bradycardia for 50 minutes but induces hypertension and pulsus alternans. ( J Am Vet Med Assoc 2001;218:52–58)Keywords
This publication has 12 references indexed in Scilit:
- Hemodynamic Effects of Medetomidine in the Dog: A Dose Titration StudyVeterinary Surgery, 1998
- Medetomidine sedation in dogs and cats:A review of its pharmacology, antagonism and doseBritish Veterinary Journal, 1996
- Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogsVeterinary Record, 1996
- Use of medetomidine and butorphanol for sedation in dogsJournal of Small Animal Practice, 1994
- Hemodynamic and analgesic effects of propofol infusion in medetomidine-premedicated dogsAmerican Journal of Veterinary Research, 1994
- Cardiac alternans: Diverse mechanisms and clinical manifestationsJACC, 1992
- Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidineVeterinary Record, 1991
- Cardiovascular and Respiratory Effects of Medetomidine in Dogs and Influence of AnticholinergicsActa Veterinaria Scandinavica, 1989
- Clinical Evaluation of Medetomidine, a Novel Sedative and Analgesic Drug for Dogs and CatsActa Veterinaria Scandinavica, 1989
- Medetomidine, a new sedative‐analgesic for use in the dog and its reversal with atipamezoleJournal of Small Animal Practice, 1989